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Abstract
Background: The mouse intravenous challenge model of Candida albicans infection is widely used to determine aspects of
host-fungus interaction. We investigated the production of cytokines in the kidneys and spleen of animals up to 48 h after
challenge with virulent and attenuated isolates and related these responses to semi-quantitative estimations of
histopathological changes in the kidney.
Methodology/Principal Findings: Progression of Candida albicans infection of the kidney in response to highly virulent
fungal strains was characterized by higher levels of host cellular infiltrate, higher lesion densities and greater quantities of
fungal elements at 24 and 48 h, and by higher kidney concentrations of IL-1b, MCP-1, KC, IL-6, G-CSF, TNF, MIP-2 and MIP-
1b, among the immune effectors measured. Levels of the chemokine KC as early as 12 h after challenge correlated
significantly with all later measurements of lesion severity. Early renal IL-6 and MIP-1b concentrations also correlated with
subsequent damage levels, but less significantly than for KC. All chemokines tested appeared in kidney homogenates, while
most of the cytokines were undetectable in kidney and spleen homogenates. GM-CSF and IL-10 showed inverse correlations
with measures of lesion severity, suggesting these alone may have exerted a defensive role. Spleen levels of KC at all times
showed significant associations with kidney lesion measurements.
Conclusions/Significance: Elevated chemokine levels, including KC, represent the earliest responses to C. albicans infection
in the mouse kidney. Fungal strains of low mouse virulence stimulate a lower innate response and less host infiltrate than
more virulent strains. These findings are consistent with immunopathological damage to kidneys in the mouse C. albicans
infection model and with growing evidence implicating some TLR pathways as the main point of interaction between
fungal surface polysaccharides and leukocytes.
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Introduction
Disseminated Candida albicans infections are often difficult to
diagnose and are associated with a high mortality [1,2]. Consid-
erable research effort has gone into understanding fungal virulence
factors [3,4,5] and host immunity [6,7,8] in experimental C. albicans
infections in mice. For very many years, the mouse model for
disseminated Candida infection has involved intravenous (IV)
injection of a yeast inoculum, with time to mortality and viable
fungal burdens in tissues the main markers of differences in
virulence of fungal strains and mutants, or of differences in mouse
susceptibility to fungal challenge [9,10,11].
The kidney is the principal target organ for infection in the
mouse IV challenge model and, while sepsis has been evidenced as
the major cause of death in the mouse model [9], the extent of
kidney damage in animals showing severe symptoms is consider-
able and is likely to contribute to the overall pathology of the
disease [9,11]. It has been recognized for many years that the
disease processes in C. albicans-infected kidneys result in heavy host
leukocyte infiltrates and micro-abscess formation [12]. This
process suggests a contribution of host immune responses to tissue
damage in the kidney, a contribution long recognized [13] and
well accepted [14] for many bacterial infections. Hence we set out
to explain the pathological basis for kidney damage following C.
albicans infection.
The kidney is not the only organ affected in the mouse C.
albicans challenge model. Invasion of the brain by C. albicans occurs
in animals receiving high challenge doses [11]. In the spleen, lungs
and liver, viable fungi are gradually cleared even while infection
damage progresses in the kidneys [10,11]. Detailed studies of
pathological events in the mouse model indicate that changes
associated with disease become measurable within 3 days of
challenge with C. albicans, including body weight, systolic blood
pressure, blood glucose, urea, chloride and creatinine levels [9].
The mouse IV challenge model is a highly reproducible, long-
standing, and widely used test for investigations into host-fungus
interactionsandefficacyofantifungalagents.However,evaluationof
virulence effects solely in terms of kidney burdens and survival times
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examine host immune responses when compared to current
technologies which permit determination of levels of individual
cytokines, enumeration of leukocytes of different receptor types and
generation of RNA expression profile data for host and fungal cells.
Consistent experimental evidence indicates that early innate
immune responses, rather than adaptive responses, are essential for
protection of mice against IV C. albicans challenge [7,8,15] and
progress has been made ex vivo and in vivo towards identification of
specific interactions between leukocyte receptors involved in innate
responses and different surface polysaccharides in C. albicans —t h e
so-called ‘pathogen-associated molecular patterns’ (PAMPs) [16].
Spellberg and colleagues concluded that failure of the kidney to halt
progression of C. albicans infection correlates with cytokines produced
locally in the infected organ, rather than with systemic immune
responses, as represented by cytokine production in splenic cells [10].
The long-standing view has been that overall protective vs. non-
protective immunity to C. albicans challenge depends on a response
dominated by Th1 rather than Th2 cells (and this response is at least
partly a function of mouse genes Carg1 and Carg2 [7]). However,
recent work by Romani’s group suggests that IL-17-producing cells,
induced subsequent to the immediate innate responses to C. albicans,
promote damaging inflammation and impair the anti-Candida effects
of neutrophils at sites of gastric infection (reviewed in [8]).
C. albicans yeast cells that have been transported from the
bloodstream into visceral organs in experimentally infected mice
can be thought of as encountering a changing microenvironment
with progression of time. At first the fungi engage with a succession
of innate-immunity leukocytes then later lymphocytes, all involved
in a complex chemical cross-talk based at the earliest stages on
production of a mixture of chemokines and cytokines by host
leukocytes, and of surface polysaccharides and secreted proteins by
the fungus. At any temporal stage, the balance between
elimination of the fungal cells and local damage at the site of
infection will depend on the responses both of the leukocytes and
the fungus to this array of effector molecules and cells. When an
immune response is characterized as predominantly Th1 or Th2,
this reflects the overall outcome of the fungus-host interaction, but
does not indicate the component events that led to that outcome.
We hypothesized that a more detailed picture of the host-fungus
interactions that occur in a kidney infected with C. albicans could be
obtained by measurement of a greater number of chemokines and
cytokines than has previously been attempted, and by semi-
quantitative histopathological analysis of the lesions. By infecting
mice with a set of C. albicans strains chosen to represent examples
known to be of high and low virulenceinthe mouse model we aimed
to differentiate host responses and lesion parameters that correlate
with survivaland non-survival ofthe experimental infection.Because
the available evidence suggests that the early stages of host-C. albicans
interactions determine gross clinical outcomes, we confined our
monitoring of events to the first 48 h after IV challenge.
Results
Quantitation of lesions: associations with strain virulence
Our first objective was to evaluate how well the three new semi-
quantitative histopathology measurements, viz. lesion density, C.
albicans pixels per lesion and infiltrate pixels per mm
2 kidney (Fig. 1),
compared with viable kidney burdens, the conventional measure-
ments of infection progression in the mouse model. Fig. 2 shows the
dataforthe fourlesionparametersat24and 48 h,and,additionally,
at 12 h for viable kidney burdens. Error bars were often substantial
because only 3 mice were analyzed per time point for each strain.
The data showed an increase in each measurement from 24 h to
48 h for the majority of infecting strains. Two of the least virulent
strains, HUN96 and pmr1D (Table 1) showed a decrease in viable
kidney burdens between 24 and 48 h (Fig. 2a), while the highest
burdens at 48 h were for AM2003-020, J951361, IHEM16614 and
SC5314 (Fig. 2a), which were 4 of the 5 most virulent strains in a
previous study (Table 1). The highest densities of PAS-positive
pixels, representing fungal material in the kidney lesions (Fig. 2b),
lesion densities (lesions/mm
2 section; Fig. 2c) and host infiltrate
pixeldensitieswereagainallrecordedforthemost virulentstrainsin
the panel (Table 1). Thus overall strain virulence was related not
only to viable kidney burdens, but also to the density of kidney
lesions, the amount of host leukocyte infiltrate and the amount of
PAS-positive material as measured histopathologically. The viru-
lence rank scores for the 9 strains studied previously (Table 1)
showed strong statistical correlations with the 48 h means of these
four parameters (Fig. 2):mean viable burdens, r=20.67 (p=0.025),
mean kidney lesions/mm
2, r=20.74 (p=0.011), mean PAS-
positive pixels in PAS-positive lesions, r=20.64 (p=0.031), and
mean host infiltrate pixels/mm
2, r=20.52 (p=0.078).
Lesion parameters correlate with strain virulence at
different times after challenge
Fig. 3 shows examples of strong and weak cross-associations
between the data obtained by measurements of lesion parameters
for kidneys infected with 11 isolates of C. albicans. The data
available from measurements at 24 and 48 h generated 36
Figure 1. PAS-hematoxylin-stained kidney section showing C.
albicans elements and host infiltrates. a. Photograph of kidney
section. b. Lesion isolated, copied and pasted in Adobe Photoshop. c.
Higher magnification of (b) showing magic wand selection of PAS-
positive pixels. d. As c but with host infiltrate pixels selected.
Bar=50 mm.
doi:10.1371/journal.pone.0006420.g001
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viable burden data. These are summarized in Table 2 as cross-
tabulations of correlations between the various measurements of
kidney lesion histopathology and fungal burdens for animals
infected with the 11 C. albicans strains. The correlations between
the lesion parameters often reached statistical significance
(Table 2). Overall, the results in Table 2 show that infection with
the most virulent strains (Table 1) generated more lesions, more
Figure 2. Development of kidney lesion parameters over 48 h from intravenous challenge of mice with 11 C. albicans strains. Data
show means6SEMs for data from 3 mice per time point per strain. X-axis values have been jittered to facilitate visualization of the data. (a) Viable
fungal burdens in kidneys. (b) C. albicans per lesion as PAS-positive pixels/lesion. (c) Lesion density (lesions/kidney section). (d) Host infiltrate pixels/
mm
2. Strains are depicted as follows. J990102, open circles; J951361, filled squares; AM2003-020, open triangles; IHEM16614, open diamonds; SC5314,
closed circles; s20175.016, open squares; AM2003/0074, filled diamonds; AM2003/0069, open circles with dotted lines; HUN96, filled squares with
dotted lines; Capmr1, open triangles with dotted lines; Capmr1+PMR1, filled triangles with dotted lines.
doi:10.1371/journal.pone.0006420.g002
Table 1. Details of the 11 C. albicans strains used in this study.
Isolate no. Virulence MLST data Country Source ABC MTL
Survival time
(days) Kidney
Weight
change
Virulence rank
a Clade DST of isolation of isolate type type Mean6SD
b
Log CFU/g
(Mean6SD)
b
day 0–3
(Mean6SD)
b
J990102 1 3 45 Belgium vagina B a/a 6.560.8 7.160.3 210.364.3
J951361 5 1 44 UK blood A a/a 5.361.6 6.161.6 215.164.6
AM2003-020 7 4 124 UK oropharynx C a/a 13.268.9 7.160.8 29.964.4
IHEM16614 8 2 206 Rwanda oropharynx A a/a 7.361.4 6.460.6 29.963.3
SC5314 9 1 52 USA blood A a/a 6.861.6 6.061.0 215.762.2
s20175.016 20 4 124 Israel blood C a/a 26.263.0 6.961.2 27.065.9
AM2003/0074 34 3 198 UK blood B a/a 27.361.6 6.061.2 1.165.0
AM2003/0069 35 2 194 UK vagina A a/a 24.564.2 4.961.7 0.763.2
HUN96 42 1 116 UK blood A a/a 28.060.0 4.062.2 1.763.6
NGY355 (pmr1D) SC5314 28.060.0 2.962.0 21.562.0
NGY356 (pmr1/PMR1) SC5314 16.267.2 5.161.8 29.261.0
aamong 43 isolates from prior study [37]. The 43 isolates were separately ranked for mouse virulence by mean survival time, terminal viable kidney burdens and weight
change from day 0 to day 3, and the ranks combined to give the overal placing among the 43 isolates as shown in this table. The first five isolates listed therefore
represent highly virulent strains, and the next four represent isolates of low virulence.
bhistorical data [37].
doi:10.1371/journal.pone.0006420.t001
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not, than infection with the least virulent strains.
Chemokine levels are the first to rise in tissues of mice
infected with C. albicans
Figs. 4 and 5 show the concentrations of the most abundant
chemokines and cytokines in organ samples at 12, 24 and 48 h.
Chemokines MCP-1 (Fig. 4), MIG (Fig. 4), and KC (Fig. 5) were
abundant in samples from infected kidneys by 12 h after challenge.
MIG was the most abundant chemokine at all time intervals in
kidney samples (Fig. 4). However, while levels of KC and MCP-1
tended to rise in kidneys of mice infected with all 11 strains over the
48 h period of measurement, MIG levels rose between 24 h and
48 h only for animals infected with J990102, SC5314 and pmr1/
PMR1. For the remaining isolates MIG concentrations were similar
at 24 and 48 h or fell from a peak at 24 h (Fig. 4). Detectable levels
ofGM-CSFweremeasuredat12 hforsomekidneysamples(Fig.5),
but they remained low (below 100 pg/g on average) throughout the
time courseoftheexperimentwiththeexceptionofthe48 hkidneys
from mice infected with pmr1/PMR1.
Chemokine and cytokine concentrations tended to be
higher in kidneys of mice infected with virulent strains
By 24 h after C. albicans challenge, kidney levels of IL-1b (Fig. 4),
G-CSF, IL-6, TNF, and MIP-1b (all Fig. 6) had risen substantially.
Fortheseeffectors, as wellaschemokinesKC (Fig.5),MCP-1 (Fig.4),
and MIP-2 (where measured; see supplementary table S1), levels in
infected kidneys by 48 h were generally highest for mice infected with
the most virulent strains (Table 1). Among the kidney samples, data
for IL-10 alone (Fig. 6) showed no consistent trend. Mean levels of IL-
10 for kidneys from mice infected with pmr1D and AM2003/0074
were higher than for miceinfected with the other 9 strains throughout
the time course. At 24 h kidney levels of RANTES (Fig. 5) were also
higher in mice infected with the more virulent strains, but this pattern
was lost by 48 h. Among the 20 cytokines and chemokines measured
in kidney samples 12, 24 and 48 h after challenge, IFN-c,I L - 2 ,I L - 3 ,
IL-4, IL-5, IL-9, IL-12p70, IL-13 and IL-17 levels were undetectable
in more than 90% of kidney samples at any time. To confirm this
unexpected negative finding we retested IFN-c and IL-12p70 by
immunoassay as many samples as residual homogenate volumes
allowed, together with two homogenates spiked with IFN-c and IL-
12p70. The results estimated the spiked cytokine levels to within 20%
of the spiked concentrations, but confirmed there were no detectable
levels of the cytokines listed above in the native samples. In spleen
samples, the same cytokines plus G-CSF, IL-6 and TNF were
undetectable in more than 90% of samples. Hence data for these
immune effectors were not analyzed further.
Cytokine and chemokine levels in spleen differed
markedly from those in kidney samples
In spleen samples from mice infected with 11 C. albicans strains,
chemokine KC and cytokine IL-1b were present at easily
Figure 3. Scatterplots of lesion parameters. Each point represents the result for a single animal, with 3 animals per C. albicans isolate. In each
figure the solid line is the regression line and the dashed curves indicate the 95% confidence region. (a) Lesion density (48 h) vs. C. albicans kidney
burdens (48 h). (b) Lesion density (48 h) vs. infiltrate density(48 h). (c) C. albicans pixel density (24 h) vs. infiltrate pixel density (24 h). (d) C. albicans
pixel density (48 h) vs. infiltrate pixel density (48 h).
doi:10.1371/journal.pone.0006420.g003
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chemokines and cytokines reached more substantial concentra-
tions by 24 and 48 h (Figs. 4–6). G-CSF, IL-6 and TNF, which
were found in 24 h and 48 h kidney samples, were undetectable at
all times in spleens. RANTES concentrations in spleen (Fig. 5)
followed a time course different from all other cytokines and
chemokines measured. Mean control levels of this chemokine in
spleen from saline-injected mice were 4300 pg/g at 12 h,
7500 pg/g at 24 h and 6400 at 48 h. These values exceeded the
concentrations measured for spleen samples from C. albicans-
infected animals at all three times, indicating downregulation of
this chemokine in response to infection. By 48 h, spleen RANTES
concentrations from most infected animals were still lower than
controls (Fig. 5) but showed recovery from their 24 h low values.
The highest RANTES spleen levels at 48 h were measured for
mice infected with the least virulent isolates.
By 48 h, GM-CSF levels in spleens were greater than those in
kidney samples (Fig. 5). However, apart from GM-CSF and
RANTES, the spleen chemokine and cytokine responses to C.
albicans infection were of a lower magnitude than responses in the
kidney (Figs. 4–6). MIG levels in spleen at 48 h were highest for
mice infected with the lowest virulence strains, while MCP-1 levels
in spleens at 48 h were highest for mice infected with the most
virulent strains. Spleen levels of IL-10 (details not shown), like
those of IL-10 in the kidney (Fig. 6) were generally low at all times,
with means never exceeding 300 pg/g, and similar to the kidney
samples, showed no clear trends over the 48 h period of
measurement.
Statistical associations confirm KC as an early predictor of
kidney damage
The tendency for higher levels of some cytokines and
chemokines to develop in the kidneys of mice infected with the
most virulent C. albicans strains (Figs. 4–6) was reflected in a
statistical analysis of associations between measurements of
immune effectors and lesion parameters. Fig. 7 shows examples
of strongly and weakly associated lesion parameters and cytokine
or chemokine levels.
The associations between immune mediators and lesion
parameters were explored in detail by statistical analysis for
significant correlations between cytokine or chemokine levels at
each of 3 sample times vs kidney lesion parameters at 24 and 48 h
(Table 3). Associations are shown both as Pearson’s correlation
coefficients (r) and as F-ratios from univariate ANOVA tests.
Table 4 reduces Table 3 to a simpler list of associations, in which
cytokine or chemokine measurements that showed 3 or fewer
statistically significant associations with lesion data at all
measurement times have been omitted. The values of r and F
have been replaced with a score from 0 to 4 that indicates the
statistical strength of each association. In this system, 0 indicates
no statistically significant association, and the score is increased by
1 for each r or F value significant at p,0.01, and by 2 for each r or
F value significant at p,0.001.
From the overview of associations provided in Table 4 it can be
seen that the earliest strong association between immune effector
concentrations and kidney lesion parameters were for KC
concentrations in the kidneys at 12 h, which significantly
associated with 24 h data for lesion densities, C. albicans pixels,
infiltrate pixels and viable burdens. Kidney levels of MIP-1b and
IL-6 at 12 h also correlated, but less strongly than for 12 h KC
levels, with two lesion parameters at 24 h.
In general, 24 h cytokine concentrations in the kidney showed
the highest level of statistical association with kidney lesions
(Table 4), with 24 h measurements of IL-6, KC, MIP-2, TNF, G-
CSF, IL-1 b, MCP-1 and MIG significantly correlated with all 4
lesion parameters at 24 h. Many of the correlations also remained
significantly correlated with 48 h lesion parameters (Tables 3 and
4). G-CSF alone showed a higher level of significant correlation
between its kidney concentration at 48 h and 48 h lesions. For the
other chemokines and cytokines, kidney concentrations at 48 h
showed less or no correlation with lesion parameters. These data
were consistent with a temporal pattern of immune effector
production in the kidneys in response to C. albicans challenge in
which levels of most effectors correlated with number and severity
of lesions, with KC, MIP-1 b and IL-6 the earliest lesion-
correlated molecules to appear and G-CSF the latest.
For GM-CSF and IL-10 the sign of the correlation coefficients
was predominantly negative (Table 3), indicating that higher levels
of these two effectors were associated with lower levels of kidney
damage. For all other chemokines and cytokines measured in the
kidneys the correlations were positive
An unexpected finding was a correlation between levels of some
immune effectors in the spleen and lesions in the kidney. Spleen
KC, at all three sample times, showed statistically significant
Table 2. Correlation coefficients (Pearson r) cross-tabulated for means of lesion data for 11 C. albicans strains.
Time Fungal kidney burdens Lesion density Infiltrate density C. albicans pixels/lesion
(h) 12 h 24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h
Viable fungal burdens 12
24 0.41
48 0.63 0.57
Lesion density 24 0.55 0.59 0.76*
48 0.40 0.54 0.84* 0.81*
Infiltrate density 24 0.43 0.49 0.51 0.71* 0.57
48 0.12 0.36 0.73* 0.53 0.85* 0.16
C. albicans pixels/lesion 24 0.60 0.73* 0.62 0.72* 0.56 0.90* 0.19
48 0.20 0.02 0.51 0.63 0.67 0.73* 0.35 0.48
For each time point N=33 samples (3 per infecting strain).
Numbers in boldface type indicate p#0.05; an asterisk indicates p#0.01. Data shown are all correlation coefficients, so the original units of measurement are not stated
in the column headings. Data for fungal kidney burdens were log10 CFU/g kidney, and for lesion densities as lesions/mm
2 and for infiltrate densities as pixels/mm
2.
doi:10.1371/journal.pone.0006420.t002
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and 48 h (Tables 3, 4), with a particularly strong association
between 24 h spleen KC concentrations and 24 h kidney lesions.
There was also significant association between 24 h spleen
concentrations of both IL-1 b and MIG and three of the four
kidney lesion measurements (Table 4), while 48 h spleen levels of
G-CSF correlated with 48 h lesion measurements.
No other spleen measurements of cytokine or chemokine
concentrations were so consistently associated with kidney lesion
parameters. The clear association of spleen KC levels with all four
lesion parameters prompted us to analyze the associations between
spleen and kidney KC levels. The results (Table 5) unequivocally
demonstrate the strongest correlations were between KC concen-
trations measured in the two tissues at the same time. Fig. 8 shows
the raw data for these strongest correlations as scatterplots. At each
measurement time, KC levels in kidneys were approximately twice
as high as those in spleen samples.
Discussion
This study demonstrates that, in the mouse intravenous C.
albicans challenge model, early interactions between the fungus and
host predict the level of gross progression of disease in the kidney,
the major organ affected in the model [9,11]. Our study is the first
we are aware of to link cytokine or chemokine production with
refined histopathological measurements of lesion development in
the mouse model. Because we measured immune effector
concentrations at different stages in the progression of renal
Figure 4. Time course of concentrations (ng/g) of the three most strongly concentrated cytokines or chemokines in supernatants
from kidney homogenates after infection of mice with 11 C. albicans strains, together with corresponding data for spleen
homogenates. The mean6SEM of 3 observations are shown for each time point measured (12 h, 24 h and 48 h). X-axis jitter has been used to aid
visualization of the data points. For each immune effector, the scale for the kidney and spleen data is the same, to allow comparison of levels
between the two tissues assayed. In each graph, the 11 strains are distinguished as follows: J990102, open circles, solid lines; J951361, filled squares,
solid lines; AM2003-020, open triangles, solid lines; IHEM16614, open diamonds, solid lines; SC5314, filled circles, solid lines; s20175.016, open squares,
solid lines; AM2003/0074, filled diamonds, solid lines; AM2003/0069, open circles, dotted lines; HUN96, filled squares, dotted lines; Capmr1, open
triangles, dotted lines; Capmr1 + PMR1, solid triangles, dotted lines.
doi:10.1371/journal.pone.0006420.g004
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molecules from the statistical associations between their concen-
trations and the four parameters relating to lesion development in
the kidney.
The significant and ubiquitous association of 12 h kidney KC
concentrations with subsequent kidney lesion parameters (Tables 3,
4) strongly implicates this chemokine, the murine analog of human
CXCL8/IL-8, which works in conjunction with MIP-2, as an
important, early produced factor in the development of the host
response to C. albicans in kidney parenchyma. Its main role is as a
chemoattractant in mobilization of leukocyte infiltrates. A recent
mouse study showed that resident tissue macrophages are the main
source of KC and MIP-2 [17], although all types of kidney cells
are able to express cytokines and chemokines in vitro [18]. KC and
MIP-2 are both transcriptionally regulated by signalling through
TLR2, TLR3 and TLR4 [17]; with TLR2 and TLR4 well
established as primary receptors in recognition of C. albicans
polysaccharides and susceptibility to experimental systemic C.
albicans infection [16,19]. The effect of KC and MIP-2 production
is ‘‘robust neutrophil recruitment’’ to the site of infection [17]. We
therefore hypothesize that KC production, a result of the
interaction between C. albicans surface mannans and glucans and
toll-like receptors, is a critical early event that mobilizes the host
infiltrates seen in the kidney.
Among the many host-fungus correlations of interest in this
study is the consistent finding that more severe disease (higher
lesion densities, C. albicans pixels and viable tissue burdens),
resulting from the most virulent challenge strains, associates with
higher levels of host leukocyte infiltrates (Table 2), as well as with
kidney levels of many cytokines and chemokines (IL-6, KC, MIP-
1b, MIP-2, TNF, G-CSF, MCP-1 and MIG dominate the list in
Table 4). We consider these results suggest that a heightened host
(innate) immune response to C. albicans in the mouse model may
worsen kidney pathology by generating inflammation, rather than
protecting the host. A very extensive literature, dating back many
years, defines innate immune responses based on polymorphonu-
clear leukocytes (PMNs) and macrophages as the principal cellular
elements of defense against C. albicans invasion, responsible for
phagocytosis and intracellular killing of the fungi (examples of
reviews are [16,19,20]). However, as was first shown [21] and
confirmed [22] many years ago, virulent C. albicans isolates are
more likely than others to kill and escape from PMNs in vitro. The
Figure 5. Time course of concentrations (ng/g) of KC, RANTES and GM-CSF in kidney and spleen samples from mice infected with
11 different C. albicans strains. Details as in Fig. 4.
doi:10.1371/journal.pone.0006420.g005
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infected with more virulent isolates may be associated with
difficulties of eradicating the fungus in the kidney, with products
from destruction of PMNs contributing to local tissue damage.
It has been previously acknowledged that the balance in innate
responses between (beneficial) fungicidal immunity and (detrimen-
tal) inflammatory cytotoxicity determines levels of tissue damage in
fungal infections [19]. Moreover, the generally adverse patholog-
ical role of inflammatory responses to many types of infection has
been recognized since the 1970s [13]. However, the emphasis of
research into anti-Candida phagocytic function by host leukocytes
has assumed this function is purely defensive. While innate
responses have been shown to contribute to pathological changes
in the human vagina in experimental C. albicans challenge
experiments [23], relatively few studies have generated direct
evidence for any tissue-damaging role of host innate immune
responses in the mouse disseminated C. albicans infection model
[24]. The view of phagocytosis purely as a host defense against C.
albicans infection is challenged by the empirical observation of
micro-abscess formation in kidneys [12]: our data show the host-
fungus interaction in the C. albicans mouse challenge model is
comparable with that well-known for bacterial infections in which
phagocytic processes contribute to host damage [14].
The evidence from the present study shows unequivocally that
kidney tissue damage is related quantitatively to the level of the host
innate response. This finding is also in accordance with the
growing body of evidence showing lowered cytokine production
from monocytes and PMNs stimulated in vitro with virulence-
attenuated C. albicans mutants bearing deficient or abnormal cell-
wall polysaccharides [16,25–27]. If innate responses have a purely
defensive role, then such reduced cytokine production should
result in greater fungal proliferation in vivo. From the evidence of
the present study, C. albicans strains naturally attenuated in gross
virulence for mice, including the mannan-depleted mutant pmr1D,
do not induce a strong innate immune response at the early stages
of infection. The studies just cited are examples of those exploring
the detailed interaction of C. albicans surface macromolecules with
host cell receptors in vitro, with toll-like receptors and dectin-1
shown to be those most involved in the fungal pathogen
recognition process.
Figure 6. Time course of concentrations (ng/g) of the chemokine MIP-1b in kidney and spleen samples, and of four cytokines
measured in kidney samples. Among the latter only IL-10 was measurable in spleen samples (see text). Details as in Fig. 4.
doi:10.1371/journal.pone.0006420.g006
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produced during experimental C. albicans infections agree well
with those of other studies. Yamamoto et al. [28] showed that levels
of mRNAs encoding IL-1b, IL-6, GM-CSF, MIP-1b, MIP-2, and
KC rose in macrophages exposed to C. albicans in vitro. They also
showed these changes were regulated via the macrophage
mannose receptor [28], now known as the site for specific binding
of N-linked C. albicans cell wall mannans [27]. We also found
increases in the kidney levels of IL-1b, IL-6, MIP-1b and KC in
our model (Figs. 4–6).
The tissue specificity of mouse cytokine responsesto disseminated
C. albicans infection has been demonstrated before [10]. However,
KC was not only the earliest cytokine in the kidney whose levels
gave the best statistical correlation with all four lesion parameters, it
was also produced by 12 h in the spleen. By 24 h, spleen KC
concentrations correlated very strongly with 24 h estimates of lesion
density, C. albicans pixels, infiltrate pixels and viable burdens in the
kidney (Tables 3, 4). These associations led us to correlate levels of
KC in spleen and kidney samples directly (Table 5, Fig. 8). There
were very strong associations between KC levels in kidney and
spleen at each sample time, with kidney levels approximately twice
those in spleen samples. We interpret these results as indicating
either that KC produced in the kidney enters the circulation and is
therefore detectable in the spleen but at lower levels, or that KC is
produced in both organs in proportionate response to C. albicans
infection, with the spleen generating less KC than the kidney. Our
experimentaldesigndidnotincludemeasurementofserumcytokine
and chemokine levels, since our interest was in local responses to
infection in one organ that ultimately clears infectionand another in
which infection progresses.
Apart from KC, IL-6 and MIP-1b were the only other cytokine
and chemokine with 12 h kidney levels that correlated with two or
more lesion parameters at 24 h (Tables 3, 4). Expression of IL-6
has been previously associated with recruitment of neutrophils to
the site of C. albicans infection in mice, and animals genetically
deficient in IL-6 showed enhanced susceptibility to IV C. albicans
challenge [29,30]. Comparison of mice lacking genes encoding
both G-CSF and IL-6 with their counterparts lacking G-CSF
showed greater susceptibiliy to C. albicans challenge in the former
[31]. While these data all suggest a protective role for IL-6 in
experimental murine C. albicans infections, it is notable that IL6
—/— mice rendered neutropenic before C. albicans challenge had
72 h viable organ burdens indistinguishable from those of
neutropenic control animals and higher than in mice with normal
neutrophil counts [29]. Hence, in all situations the development of
tissue pathology in C. albicans-infected mice appears to depend very
much on relative balances of cytokine or chemokine production
and of neutrophil recruitment to the kidney. Some degree of
response involving cytokine expression and neutrophil recruitment
is clearly required for host defense against C. albicans: perhaps a
Figure 7. Scatterplots of cytokine or chemokine concentrations in kidney samples vs. lesion parameters for animals infected with
11 C. albicans strains: 3 points per strain. (a) GM-CSF at 24 h vs viable fungal burdens at the same time; r=0.08, p=0.33. (b) KC at 12 h vs lesion
density at 24 h; r=0.84, p,0.001. (c) KC at 12 h vs lesion density at 48 h; r=0.67, p,0.001. (d) GM-CSF at 48 h vs viable fungal burdens at the same
time; r=20.61, p,0.001. (e) RANTES at 24 h vs mean C. albicans pixels per PAS-positive lesion; r=20.05, p=0.41. (f) 24 h IL-6 vs mean host infiltrate
pixels per mm
2 section; r=0.77, p,0.001.
doi:10.1371/journal.pone.0006420.g007
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PLoS ONE | www.plosone.org 9 July 2009 | Volume 4 | Issue 7 | e6420Table 3. Statistical associations between cytokine and chemokine measurements in kidney and spleen samples, measured at 12,
24 and 48 h, and kidney lesion parameters measured at 24 and 48 h in mice infected with 11 C. albicans strains.
Cytokine/
chemokine
Time
(h) Lesions/mm
2 C. albicans pixels/lesion Infiltrate pixels/mm
2 log CFU/g kidney
24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h
r
a F
b rF rF r F r F r F r F rF
Kidney GM-CSF 12 20.04 1.0 0.11 1.6 20.06 0.1 0.01 0.3 0.02 0.5 20.03 0.0 0.07 0.3 20.18 0.0
24 20.39 6.7 20.14 1.4 20.15 0.8 20.20 1.5 20.26 2.6 20.06 0.1 0.08 0.1 20.25 2.2
48 20.29 3.6 20.34 4.3 20.36 4.4 20.07 0.2 20.06 0.1 20.37 4.3 20.37 5.1 20.61* 18*
IL-10 12 20.23 0.9 20.05 0.4 20.16 0.8 20.17 0.1 20.25 0.1 0.08 1.3 0.14 0.1 20.03 0.3
24 20.40 1.8 20.20 0.0 20.16 1.1 20.22 0.1 20.29 0.0 20.09 0.3 0.08 0.4 20.20 0.2
48 20.39 0.2 20.38 2.6 20.30 3.2 20.31 1.5 20.29 0.5 20.25 0.9 20.14 2.0 20.50 8.2
IL-6 12 0.38 1.0 0.31 0.8 0.03 6.8 0.15 0.6 20.02 8.1 0.21 0.6 0.02 9.6 0.29 0.3
24 0.85* 36* 0.55* 3.8 0.77* 44* 0.41 0.3 0.75* 27* 0.24 0.5 0.68* 73* 0.63* 7.4
48 0.58* 1.8 0.43 1.1 0.40 0.6 0.77* 30* 0.68* 7.4 0.14 0.0 0.06 20* 0.46 0.8
KC 12 0.69* 0.3 0.72* 6.9 0.42 1.2 0.32 0.0 0.37 1.1 0.55* 4.7 0.49 0.8 0.68* 2.0
24 0.85* 15* 0.67* 0.1 0.66* 16* 0.41 0.0 0.61* 6.9 0.48 1.3 0.70* 33* 0.76* 2.0
48 0.66* 0.9 0.62* 3.2 0.35 1.3 0.53* 4.5 0.48 0.3 0.62* 9.2 0.22 12 0.74* 7.8
MIP-1b 12 20.30 11 20.30 8.4 20.13 4.8 20.26 0.0 20.17 1.5 20.21 3.3 0.02 12 20.41 18*
24 0.40 11 0.36 8.3 0.49 11 0.03 2.4 0.34 2.2 0.29 3.8 0.67* 43* 0.33 12
48 0.68* 13 0.57* 5.2 0.50 2.6 0.77* 42* 0.71* 17* 0.40 1.3 0.18 2.5 0.61* 6.8
MIP-2
c 12 0.41 0.7 0.56 5.4 0.15 0.8 0.32 0.6 0.04 2.1 0.53 7.2 0.14 1.4 0.59 11
24 0.89* 25* 0.69 2.4 0.77* 10 0.40 1.0 0.71* 11 0.38 0.9 0.81* 15 0.72* 2.0
48 0.64 1.7 0.64 3.7 0.67 2.5 0.23 0.0 0.52 0.2 0.61 8.9 0.67 2.5 0.75* 13
RANTES 12 0.31 2.5 0.43 5.8 0.31 2.8 0.35 4.2 0.32 3.0 0.21 0.7 0.18 0.5 0.30 1.9
24 0.20 0.7 0.21 1.2 0.15 0.7 20.03 0.5 0.10 0.1 0.31 3.0 0.41 7.2 0.36 3.7
48 0.04 0.0 20.14 1.5 20.15 1.3 0.10 0.4 0.04 0.0 20.08 0.8 20.13 2.2 0.01 0.2
TNF 12 20.15 4.1 0.10 0.0 20.17 7.8 20.01 0.1 20.24 7.3 0.12 0.0 0.09 1.6 0.07 0.0
24 0.66* 18* 0.48 6.7 0.71* 31* 0.28 0.0 0.60* 14 0.27 3.7 0.78* 51* 0.50 5.4
48 0.59* 5.1 0.19 0.0 0.45 0.5 0.59* 11 0.66* 11 20.12 2.2 0.21 2.9 0.33 0.5
G-CSF 12 0.33 0.6 0.38 4.4 0.17 0.2 0.11 0.0 0.20 0.0 0.12 1.1 0.13 0.5 0.17 0.0
24 0.73* 11 0.54* 0.4 0.65* 10 0.53* 1.7 0.68* 8.8 0.18 1.9 0.52* 10 0.55* 2.3
48 0.63* 5.9 0.68* 16* 0.50 1.4 0.70* 13 0.63* 6.0 0.57* 15 0.18 0.9 0.63* 7.9
IL-1b 12 20.15 1.4 20.19 1.3 0.02 0.0 20.04 0.0 0.08 0.3 20.05 0.3 0.08 0.3 20.16 1.9
24 0.57* 10 0.36 2.5 0.57* 13 0.28 1.5 0.49 8.6 0.17 0.0 0.61* 14 0.41 1.8
48 0.29 0.4 0.19 0.3 0.18 0.3 0.16 0.1 0.17 0.2 0.28 1.8 0.25 0.0 0.42 4.1
MCP-1 12 0.20 0.1 0.46 4.2 0.26 0.0 0.16 0.8 0.16 0.0 0.30 1.1 0.30 0.5 0.41 2.7
24 0.63* 5.0 0.54* 0.5 0.53* 6.9 0.14 0.6 0.45 3.6 0.52 0.1 0.74* 47* 0.62* 0.9
48 0.60* 3.2 0.54* 4.3 0.28 0.3 0.31 3.0 0.31 0.0 0.66* 10 0.22 10 0.68* 10
MIG 12 0.01 3.2 0.30 0.4 0.19 0.0 0.03 0.2 0.20 0.0 0.14 0.0 0.15 0.3 0.14 0.4
24 0.55* 16* 0.48 5.3 0.54* 11 0.20 1.0 0.46 6.0 0.36 3.1 0.58* 21* 0.54* 11
48 0.21 1.0 0.14 0.1 20.03 0.5 0.28 2.0 0.18 0.4 0.20 0.7 20.28 7.8 0.19 0.5
Spleen GM-CSF 12 20.54 11 20.35 3.3 20.27 1.6 20.28 2.2 20.25 1.2 20.32 2.8 20.22 1.0 20.45 6.3
24 20.24 1.1 20.13 0.0 20.23 0.5 20.11 0.1 20.26 1.0 20.01 0.3 20.20 0.6 20.09 0.0
48 0.10 0.0 0.34 2.8 0.39 3.8 0.04 0.0 0.30 1.9 0.27 2.0 0.19 0.5 0.27 1.6
IL-10 12 20.15 0.7 20.16 0.7 20.06 0.1 20.15 0.6 0.05 0.1 20.21 1.2 0.03 0.0 20.23 1.5
24 0.19 1.0 20.03 0.1 0.07 0.1 0.13 0.5 0.03 0.0 20.17 1.3 20.09 0.2 20.15 1.0
48 0.21 1.2 0.44 6.8 0.34 3.8 0.09 0.2 0.29 2.6 0.41 6.0 0.14 0.6 0.41 6.0
KC 12 0.49 0.2 0.50 2.2 0.40 0.1 0.22 0.2 0.38 0.1 0.36 0.5 0.41 0.1 0.57* 3.0
24 0.79* 26* 0.53 1.4 0.67* 14* 0.24 0.1 0.62* 10 0.41 0.2 0.76* 32* 0.66* 4.3
48 0.46 1.4 0.53 3.0 0.28 0.0 0.27 0.7 0.31 0.1 0.56* 6.3 0.17 2.1 0.63* 6.1
MIP-1b 12 0.23 1.3 20.05 0.1 0.00 0.0 0.05 0.0 0.01 0.0 20.18 0.9 20.10 0.7 20.06 0.3
Experimental Candida Infection
PLoS ONE | www.plosone.org 10 July 2009 | Volume 4 | Issue 7 | e6420modest acute host response is more successful in eradicating the
fungus and avoiding progressive kidney damage than a more florid
host reaction in the kidney.
Progressive disease in the mouse C. albicans model has long been
associated with a predominantly Th2-type, rather than a Th-1-
type host response. More recently, the later involvement of a Th17
response in murine C. albicans infection has been implicated
(reviewed in [8]). However, the contribution of a Th17 response to
exacerbation of C. albicans burdens in a gastric model of Candida
infection [32] has to be contrasted with the unequivocally
protective effect of the Th17 response in disseminated murine C.
albicans infection [33]. Our own data showed little or no renal
production of cytokines or chemokines classically associated with a
Th1 response in association with C. albicans kidney proliferation.
IL-12, IFNc and, for that matter, IL-2, IL-3, IL-4, IL-5, IL-9, IL-
13 and even IL-17 were essentially undetectable in the great
majority of our samples. By contrast, G-CSF, TNF, and MCP-1
levels in the kidneys at 24 and 48 h showed associations with lesion
parameters at both times (Tables 3, 4), possibly indicating
involvement of these effectors in the progression of infection
subsequent to the neutrophil-recruiting early activities of KC, IL-6
and MIP-1b. Significant associations between kidney cytokine or
chemokine levels and measurements of both infiltrate and C.
albicans pixels by histopathology were seen 24 h after challenge
(Table 4). By contrast, associations between immune effector levels
and overall lesion densities and viable cell numbers were more
commonly retained at 48 h. This observation is consistent with our
interpretation of the overall outcome of infection depending on the
earliest stages of host-fungus interactions. By 48 h, neither the C.
albicans pixels nor the amount of host infiltrate was as strongly
correlated with lesion density or viable burden as at 24 h (Table 2),
suggesting that the different 48 h parameters may reflect the
outcomes of intra-lesional phagocytic processes.
Our results provide clear evidence from immunologically intact
animals for the significance of the early host response in
determining the pathological course of infection, and strongly
implicate KC, in particular, as an important early mediator of
overall outcome. However, we realize these findings are strictly
applicable only to infections in immunologically intact BALB/c
mice. Since other standard inbred mouse strains differ in their
susceptibility to C. albicans challenge, a phenomenon related to the
mouse genes Carg1 and Carg2 [34,35], our study serves as a basis
for future expansion of research into different mouse strains,
including mice with gene knockouts specific for the cytokines we
have identified as significant early factors in determining infection
outcome, and mice immunocompromised by other experimental
Cytokine/
chemokine
Time
(h) Lesions/mm
2 C. albicans pixels/lesion Infiltrate pixels/mm
2 log CFU/g kidney
24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h
r
a F
b rF rF r F r F r F r F rF
24 20.44 7.5 20.27 2.3 20.33 3.6 20.32 3.1 20.33 3.6 20.13 0.6 20.13 0.6 20.28 2.6
48 20.28 2.6 0.01 0.0 20.11 0.4 20.04 0.0 20.14 0.6 0.13 0.3 20.24 2.1 20.13 0.6
RANTES 12 0.00 0.0 0.18 0.7 0.18 1.0 0.11 0.4 0.11 0.5 0.14 0.4 0.12 0.2 0.26 1.1
24 20.10 0.9 0.08 0.0 20.03 0.3 20.10 0.6 20.11 0.9 0.11 0.1 0.08 0.0 0.26 1.2
48 20.55* 14* 20.22 1.1 20.28 2.3 20.21 1.3 20.30 3.0 20.13 0.4 20.30 2.7 20.30 2.2
TNF 12 20.29 3.0 20.24 2.2 20.26 2.3 20.19 1.1 20.14 0.7 20.19 1.4 20.05 0.1 20.34 5.3
24 20.10 0.2 20.25 1.8 20.15 0.6 0.09 0.5 20.20 0.9 20.29 1.9 20.26 1.4 20.31 2.9
48 20.21 1.2 20.18 0.5 20.15 0.5 20.23 2.1 20.17 0.6 20.29 2.0 20.28 1.8 20.32 2.9
G-CSF 12 20.26 2.0 20.22 1.1 20.21 1.3 20.19 0.8 20.13 0.3 20.19 0.8 20.04 0.1 20.32 3.0
24 0.37 3.3 0.21 0.5 0.46 6.5 0.26 0.9 0.40 4.3 20.08 0.8 0.25 2.1 0.16 0.2
48 0.44 5.4 0.44 5.4 0.44 5.2 0.61* 14* 0.59* 13 0.36 4.6 20.02 0.2 0.44 5.8
IL1-b 12 20.02 0.7 0.02 0.2 0.09 0.0 20.05 0.1 0.13 0.4 0.04 0.2 0.10 0.0 0.14 0.0
24 0.68* 24* 0.45 4.6 0.45 6.3 0.34 5.6 0.48 9.1 0.27 0.5 0.32 2.7 0.51 5.0
48 0.19 0.1 0.31 0.9 0.17 0.1 20.08 1.6 0.04 0.6 0.39 3.5 0.14 0.0 0.53 5.4
IL-9 12 20.37 5.0 20.21 1.2 20.46 9.5 20.26 1.8 20.40 6.9 0.08 0.2 20.25 2.4 20.16 1.0
24 0.14 0.6 20.18 0.9 0.09 0.0 20.28 1.6 0.10 0.0 20.10 0.7 0.09 0.0 20.01 0.4
48 0.07 0.0 20.04 0.1 0.21 2.1 20.15 0.0 0.21 1.8 0.10 0.6 0.18 1.0 0.22 2.1
MCP-1 12 20.50 11 20.20 1.1 20.14 0.6 20.29 2.5 20.27 2.4 20.19 0.9 0.01 0.0 20.21 1.3
24 0.30 3.2 0.20 0.9 0.38 4.3 20.12 0.2 0.25 1.9 0.29 2.0 0.61* 15* 0.35 3.3
48 0.41 4.4 0.26 1.1 0.24 0.8 20.04 0.1 0.20 0.5 0.32 1.9 0.32 2.1 0.38 2.7
MIG 12 20.11 0.1 20.23 0.7 20.17 0.2 0.13 0.3 20.22 0.1 20.33 1.6 20.29 0.0 20.24 0.0
24 0.40 5.2 0.45 6.4 0.54* 12.3 0.07 0.3 0.43 6.0 0.27 1.5 0.54* 13 0.46 7.4
48 20.21 1.1 20.11 0.0 20.31 3.0 0.10 0.0 20.24 0.8 20.24 0.2 20.42 5.0 20.38 3.4
ar=Pearson correlation coefficient.
bF=F-ratio from univariate analysis of variance.
cdata for mice infected with 8 of the 11 C. albicans isolates.
All data presented to two significant figures. Boldface type indicates p,0.01; an asterisk indicates p,0.001.
doi:10.1371/journal.pone.0006420.t003
Table 3. Cont.
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different tissues with the fine detail of lesion development as we
have done in this study will, in time, provide evidence for the
precise nature of the main immunostimulatory fungal components
and of the innate immune responses to them within the precise
context of whole-animal infection. Such studies will usefully
Table 4. Association scores showing the strength of correlation and ANOVA data between concentrations of cytokines or
chemokines and parameters of C. albicans kidney lesions.
Cytokine/
chemokine Time (h) Lesions/mm
2 C. albicans pixels/lesion Infiltrate pixels/mm
2 log CFU/g kidney
Association score Association score Association score Association score
24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h
Kidney IL-6 12 000010 1 0
2 4424040 4 2
4 8211420 2 1
K C 1 2221002 1 2
2 4324121 4 2
4 8220213 1 3
MIP-1b 1 2110000 1 3
2 4112000 4 1
4 8321440 0 2
M I P - 2 1 2010000 0 2
2 4413030 3 2
4 8111001 1 3
T N F 1 2001000 0 0
2 4414030 4 1
4 8201330 0 0
G - C S F 1 2000000 0 0
2 4323230 3 2
4 8241323 0 3
IL-1b 1 2000000 0 0
2 4303020 4 0
4 8000000 0 1
MCP-1 12 010000 0 0
2 4222011 4 2
4 8220003 1 3
M I G 1 2000000 0 0
2 4413010 4 3
4 8000000 1 0
S p l e e n K C 1 2110000 1 2
2 4424030 4 2
4 8110002 0 2
G - C S F 1 2000000 0 0
2 4001010 0 0
4 8111430 0 1
IL-1b 1 2000000 0 0
2 4411020 0 1
4 8000000 0 1
M I G 1 2000000 0 0
2 4013010 3 1
4 8000000 1 0
The data in Table 3 have been reduced by the following procedure. Cytokines or chemokines that showed statistically significant scores (p,0.01) with 3 or fewer lesion
parameters across all 48 h of the experiment were removed from the tabulation. For the rest, a score of 1 was assigned for each r and F in Table 3 that was significant at
the level of p,0.01, and a score of 2 for each r and F in Table 3 that was significant at the level of p,0.001. For each cross-tabulation of cytokine or chemokine with a
lesion parameter the maximum possible score is therefore 4.
doi:10.1371/journal.pone.0006420.t004
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interactions in vitro.
Methods
Ethics statement
All animal experimentation conformed with the requirements of
UK Home Office legislation for animal experimentation, and with
those of the University of Aberdeen Ethical Review Committee.
C. albicans strains
Eleven strains of C. albicans were used in the experiments. They
are detailed in Table 1. Nine of the strains were chosen to
represent the four major clades of C. albicans strain types [36], with
one high virulence and one and low virulence strain chosen from
each clade from among 43 isolates tested in a separate study [37].
The other two strains were NGY355 and NGY356; the former a
mutant with disruptions in both copies of PMR1, the latter a
heterozygous PMR1 reintegrant [38]. These two strains will be
referred to as pmr1D and pmr1/PMR1 throughout this paper. They
were included as representatives of laboratory-engineered mutants
of different virulence to determine if their behavior in vivo differed
notably from wild-type strains.
All strains were maintained in 50% glycerol stocks at 280uC
and recovered from these stocks as required for experiments. For
routine maintenance in culture, the fungi were grown on slants of
Sabouraud agar (Oxoid, Basingstoke, UK). For preparation of
inocula for mouse challenge, a yeast culture was grown for 18 h in
5 ml volumes of NGY medium, comprising 0.1% Neopeptone
(BD-Difco, Oxford, UK), 0.4% glucose and 0.1% yeast extract
(BD-Difco), incubated at 30uC with continuous rotation at 20 rpm
and an angle of 5u from the horizontal. These conditions yielded a
suspension of yeast cells in late exponential growth phase. The
yeasts were centrifuged and washed twice in sterile saline,
resuspended in saline, and enumerated with a hemocytometer.
Pairs of cells, as well as rare triplets and quadruplets, were counted
as single units, to maximize compatibility between hemocytometer
counts and viable counts, set up from the final inoculum
suspensions and enumerated the following day.
Animal model
Female BALB/c mice (Harlan, UK), weighing 18–22 g, were
supplied with food and water ad libitum. They were weighed and
infected intravenously with the C. albicans isolates at a target dose
of 3610
4 CFU/g body weight. Viable counts showed the animals
received doses ranging from 1.8610
4–5.6610
4 CFU/g, with the
median and modal doses both 3.6610
4 CFU/g. Groups of nine
animals were challenged for each strain, then 3 mice were
humanely terminated after 12 h, 24 h and 48 h. A pilot
experiment was done with strains SC5314, HUN96, J990102
and AM2003/0074 to allow us to develop and validate the
methodology used for lesion measurements and cytokine assays.
The experiment was then repeated with all 11 C. albicans strains,
and results from this experiment are presented in this paper. Data
for each time point were therefore obtained from 3 animals for
each of 11 infecting strains, with the exception of some cytokine
Table 5. Associations between KC concentrations in kidney and spleen.
Kidney KC at vs Spleen KC at 12 h vs Spleen KC at 24 h vs Spleen KC at 48 h
r FrF rF
12 h 0.85* 42* 0.628* 6.8 0.313 0.51
24 h 0.64* 4.9 0.939* 140* 0.596* 8.9
48 h 0.40 0.54 0.445 0.94 0.701* 19*
Data are presented in the same format as Table 3.
doi:10.1371/journal.pone.0006420.t005
Figure 8. Scatterplots of KC concentrations in kidney vs. spleen measured at (a) 12 h, (b) 24 h and (c) 48 h after intravenous
challenge of mice with 11 C. albicans strains.
doi:10.1371/journal.pone.0006420.g008
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IV with 100 ml saline in each experiment.
At termination, each animal was swiftly dissected under aseptic
precautions. Both kidneys and the spleen were removed. The
organs were halved longitudinally with a sterile scalpel. Two
halves from each kidney were pooled and homogenized in 0.5 ml
of sterile saline containing one Complete Protease Inhibitor Tablet
(Roche) per 50 ml. The other two kidney halves were fixed
together in 4% formaldehyde to be processed for histopathology.
The spleen halves were handled similarly: one half was
homogenized in 0.5 ml saline containing protease inhibitor and
the other fixed in formaldehyde. Weights of tissues were
determined for the homogenized samples to provide a denomina-
tor for viable count and cytokine level data.
Samples (50 ml) of kidney and spleen homogenates were used
for determination of tissue C. albicans burdens by viable counting.
(No C. albicans was recovered from any sample from mice
challenged with saline alone.) The remainder of the homogenate
was centrifuged at 2500 g for 5 min, and the supernatant stored at
220uC for subsequent assay of cytokine concentrations.
Cytokine assays
Twenty mouse cytokines and chemokines were assayed in
supernatants from tissue homogenates by means of BD cytometric
bead array (CBA) (BD, Oxford, UK). The cytokines measured
were IFN-c, G-CSF, GM-CSF, IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6,
IL-9, IL-10, IL-12p70, IL-13, IL-17, and TNF. The chemokines
measured were KC, MCP-1, MIG, MIP-1b, and RANTES.
Additionally, MIP-2 was determined by immunoassay in kidney
homogenates from animals infected with 8 of the 11 C. albicans
isolates (see below).
For each neat sample two CBA flex set reactions were set up,
each measuring ten different cytokines/chemokines. Reactions
were carried out as per the manufacturer’s instructions. CBA
reactions were analysed by flow cytometry on a FACSArray (BD,
UK). To analyze results, discrete bead populations were selected
and labelled with FCS Filter software v1.0.1 (www.softflow.com)
and concentrations of cytokines and chemokines determined from
standard curves with FCAP Array software v1.0.1 (www.softflow.
com). Standard curves (range: 10–2500 pg/ml) were determined
in the same run as the assayed samples. Homogenate samples close
to, or exceeding, the maximum point of the standard curve were
diluted and assayed again. For measurement of MIG, samples
were routinely diluted 1 in 5.
Murine IFN-c, IL-17 and IL-12p70 were assayed with
QuantikineH mouse immunoassays (R & D Systems, Abingdon,
UK) to confirm the negative results obtained in bead assays, and
MIP-2 was assayed for kidney samples from mice infected with 8
of the 11 isolates, to extend the range of chemokines tested. Assays
were conducted according to the manufacturer’s instructions, with
undiluted supernatants (50 ml) from kidney and spleen homoge-
nates obtained from C. albicans-infected BALB/c mice. Kidney
homogenates from two uninfected mice were also spiked with
either IFN-c or IL-12p70 (80–100 pg/ml) and the supernatants
assayed for cytokines.
The concentration of each cytokine was determined in units of
pg/ml, then recalculated as pg/g tissue in the sample. The
effective limit of detection for the cytokines was 25 pg/ml: samples
determined with concentrations below this level were recorded as
containing 0 pg/ml. The mean pg/g for each cytokine determined
in the equivalent tissues from mice challenged with sterile saline
was subtracted from the values for tissues from C. albicans-infected
mice to provide a final cytokine concentration resulting from
infection. A negative value was interpreted as probably indicating
downregulation of the cytokine measured. Cytokine and chemo-
kine measurements at each time point were therefore based on
N=33 (11 strains, triplicate mice).
Supplementary on-line table S1 provides the detailed values for
all lesion and cytokine measurements.
Semiquantitative histopathology
Two kidney halves from each animal were fixed in formalde-
hyde then embedded together in paraffin and sectioned longitu-
dinally at 5 mm thickness. For each animal/timepoint, kidney
lesions were subjected to semi-quantitation as described below for
one section made from the first 20 mm depth of the embedded
kidney and a second section made 80 mm below the first section.
Sections were deparaffinized, then stained with periodic acid-
Schiff’s reagent (PAS) and counterstained with hematoxylin. This
method provided sections in which C. albicans elements within
lesions were visible as red-stained, PAS-positive material, while
host leukocyte infiltrates were visualized as a darker, purple color
(Fig. 1). Adobe Photoshop CS3 software was used to determine
pixel areas of lesions and of differently colored portions of lesions
by means of the ‘magic wand tool’ set to a tolerance or 15–25 and
for selection of non-contiguous pixels of matching color. Total
pixel counts of selected areas were read from the Photoshop
histogram plots at cache level 2. The tissue sections were
photographed at a 1.26 magnification in a light box fitted with
a digital camera for determination of entire sectional areas in mm
2
from a predetermined pixel count calibration. The sections were
then scrutinized microscopically with a 10x objective and
individual lesions photographed with a digital camera. The
lesional area in each photograph was outlined with the Photoshop
‘lasso tool’, cut and pasted into a new Photoshop window. The
magic wand tool was then used to determine separately the pixel
areas of PAS-positive material and of host infiltrate within each
lesion. The spleen sections contained considerable amounts of
non-fungal PAS-positive material, and defined lesions were
difficult to discern. Similarly, in 12 h kidney specimens, well-
defined lesions and C. albicans elements were rarely seen and
seldom capable of pixel analysis. Our experience suggests that C.
albicans elements are reproducibly visible in histopathological
sections only when the viable counts in the tissues exceed 10
5/g. In
practice, we were able to obtain semi-quantitative lesion data only
for sections of kidney taken from infected animals 24 h and 48 h
after IV fungal challenge.
From the pixel data for each animal’s kidneys after 24 and 48 h,
the following determinations were made: lesion density (lesions/
mm
2 = lesion count 4 kidney area), C. albicans pixels/lesion (PAS-
positive pixels in each C. albicans-positive lesion), and host infiltrate
pixels/mm
2. Comparison of these data for the two separate
sections analyzed for each tissue block showed a high level of
agreement between the two estimates. For each animal, the data
from both sections were therefore pooled for determination of
average estimates of lesion densities and pixel counts per kidney.
In the pilot experiment, lesion areas (in pixels)and infiltratepixels
per lesion were also determined, but these measurements were
subsequently abandoned. It was found that determination of lesion
areas involved too much subjective judgement of lesion boundaries
to provide reproducible results when different operators assessed the
same lesion photographs. While the color of PAS-positive material
was sufficiently distinctive to allow reproducible assay of its pixel
area per lesion, regardless of inter-operator variations in lesional
area selected, the same was not true for the infiltrate pixel area.
Expression of the total infiltrate pixels per mm
2 of entire sections
was found to provide better inter-operator reproducibility than was
obtained for measurements of infiltrate pixels per lesion. Hence the
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lesions/mm
2, infiltrate pixels/mm
2, and PAS-positive pixels per C.
albicans-positivelesion.Additionally,tissue burdens (aslog10CFU/g)
were determined at the analysis time points.
Statistical analysis
Data were stored in Microsoft Excel spreadsheets; the SPSS
statistical package, version 17.0, was used for all analyses. The
results available for analysis were concentrations of cytokines
determined for triplicateanimals at 12,24 and 48 h insamples from
kidneys and spleens infected with 11 strains of C. albicans (9 strains in
some instances: see above), and the kidney lesion parameters —
viable fungal kidney burdens at 12 h, 24 h and 48 h and estimates
of lesion density, host infiltrate pixels/mm2 and PAS-positive (C.
albicans) pixels per Candida-positive lesion, all at 24 h and 48 h.
Comparisons of data were made on an individual animal basis.
Pearson’s correlation coefficient, r, was used to determine
associations between lesion data. For comparisons between lesion
parameters and cytokine concentrations, many of the variables
analyzed were unlikely to be fully independent of each other, so the
following approach to statistical analysis was used. To determine
associations between levels of each cytokine at each of 3 time points
and lesion measurements at 2 time points, the 6 Pearson correlation
coefficients for all possible lesion-cytokine pairs were calculated.
Additionally, a univariate analysis of variance (ANOVA) was run
with a lesion parameter at a single time point as dependent variable,
andconcentrationsofcytokinesat all three time pointsas covariates.
From all analyses, a p-value #0.01 was regarded as a significant
result and a p-value #0.001 as a highly significant result.
Supporting Information
Table S1 Lists raw data on which analyses are based
Found at: doi:10.1371/journal.pone.0006420.s001 (0.08 MB
XLS)
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